RIVastigmine In Vascular cognitivE Impairment

NCT00669344 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Cognitive Impairment

Interventions

DRUG: Exelon (rivastigmine)
DRUG: Placebo

Sponsor

Singapore General Hospital

Collaborators

[object Object]
[object Object]